ADHD is the most under-recognized co-occurring condition in adult addiction treatment. Many clients walk in carrying a diagnosis they have known about since childhood, and many more walk in with no idea that the cognitive patterns they have lived with their whole lives have a clinical name.
The combination of ADHD and substance use disorder is significantly more common than chance would predict, and treating one without recognizing the other often leads to recurrent treatment failures that look like motivational problems but are in fact undiagnosed neurodevelopmental ones.
At Roanoke Refuge, co-occurring ADHD and substance use disorder are addressed as substance-use-primary outpatient care where co-occurring mental health conditions are addressed inside the same treatment plan for adults across the Roanoke Valley. The work runs through PHP, IOP, and Telehealth IOP, with coordinated medication management through outside psychiatric prescribers. The broader dual diagnosis program describes the integrated framework in more depth.
What ADHD Is
ADHD is a neurodevelopmental condition characterized by persistent patterns of inattention, hyperactivity, and impulsivity that significantly affect daily functioning. The American Psychiatric Association recognizes three presentations in the DSM-5: predominantly inattentive, predominantly hyperactive-impulsive, and combined. ADHD often presents differently in adults than in children, with hyperactivity sometimes manifesting as internal restlessness rather than visible motor activity, and inattention often appearing as chronic difficulty with planning, organization, and follow-through.
Adult ADHD is a legitimate clinical diagnosis grounded in decades of research. The condition is associated with specific neurobiological patterns, including differences in dopamine and norepinephrine signaling and in the function of prefrontal cortical regions involved in executive function. The diagnosis is made through clinical assessment, often including standardized rating scales, careful developmental history, and observation of current functioning across multiple domains.
What the Research Shows on ADHD and Substance Use
The co-occurrence of ADHD and substance use disorder is established across a substantial body of research, summarized by the National Institute on Drug Abuse, the National Institute of Mental Health, and major reviews in both literatures. The consistent finding is that adults with ADHD develop substance use disorders at rates two to three times higher than adults without ADHD.
The relationship is observed across a range of substances. Alcohol, cannabis, nicotine, stimulants, and opioids are all used at elevated rates by adults with ADHD compared to controls. The reasons are multiple:
- Self-medication of ADHD symptoms.
- Impulsivity that increases the likelihood of substance experimentation and continued use.
- The interaction of ADHD with co-occurring conditions like anxiety and depression.
- The social and occupational difficulties that often surround untreated ADHD.
The research also supports a particular clinical implication. Untreated ADHD is associated with worse outcomes in substance use disorder treatment, and treated ADHD is associated with better outcomes. Identifying and treating co-occurring ADHD is part of effective substance-use-primary care with co-occurring mental health addressed in the same plan care.
How ADHD and Substance Use Disorder Connect
The connections between ADHD and substance use disorder are multiple, and naming them helps clients and families understand the clinical picture.
Self-Medication of ADHD Symptoms
Many adults with undiagnosed or untreated ADHD describe substance use that, in retrospect, looks like an attempt to manage ADHD symptoms. Stimulants, including cocaine and methamphetamine, are sometimes used in patterns that mimic the effect of prescribed stimulant medication, with reports of improved focus and reduced restlessness. Cannabis is sometimes used to manage the internal restlessness and difficulty sleeping that often accompany ADHD. Alcohol is sometimes used to quiet the racing thoughts and chronic overstimulation that ADHD can produce.
Impulsivity
Impulsivity is a core feature of ADHD and a core risk factor for substance use disorder. The clinical literature suggests that the impulsivity associated with ADHD increases both the likelihood of initiating substance use and the likelihood of continued use despite consequences.
Executive Function and Recovery
Executive function difficulties, including challenges with planning, working memory, and follow-through, are central to ADHD and create specific challenges in recovery. Standard treatment structures often assume executive function skills that adults with ADHD may not have. Without specific attention to these challenges, the treatment can feel impossibly disorganizing.
Co-Occurring Anxiety and Depression
ADHD frequently co-occurs with anxiety, depression, and other mental health conditions, and the multiple co-occurrences interact with substance use in complex ways. The substance-use-primary care with co-occurring mental health addressed in the same plan framework holds all of these together within one treatment plan.
How We Treat Co-Occurring ADHD and Substance Use at Roanoke Refuge
Treating ADHD inside the substance-use-primary plan addresses both conditions together. The specific clinical elements include the following.
- Careful diagnostic assessment — Screening for ADHD during the intake assessment, with referral to outside psychiatric providers for formal diagnostic evaluation when indicated. Diagnostic clarity often requires observation across periods of sustained abstinence.
- Medication coordination — Stimulant and non-stimulant medications for ADHD are coordinated with outside prescribers in the Roanoke region.
- Substance use disorder treatment: Evidence-based behavioral therapies including CBT adapted for the cognitive patterns of ADHD, DBT skills for impulse regulation, and Motivational Interviewing for ambivalence.
- Executive function support — Practical strategies for managing the executive function challenges that often complicate recovery, including scheduling, follow-through, and the structure of the treatment plan itself.
- Group programming designed with ADHD in mind — Group structures that account for attention challenges, with breaks, varied formats, and active participation.
- Recurrence-prevention planning that accounts for ADHD — A written plan that addresses both the substance use triggers and the ADHD-related vulnerabilities, including periods of low structure, transitions, and high cognitive demand.
- Family involvement: The relational impact of ADHD and substance use is significant, and the Family Programfamily therapy are part of the work.
The Stimulant Medication Question
One of the most common questions families ask is whether stimulant medication for ADHD is appropriate in the context of substance use disorder. The clinical literature on this question is nuanced, and the decision is made between the client and the prescribing provider, not by Roanoke Refuge.
What the research generally supports is the following:
- For some adults with co-occurring ADHD and substance use disorder, the benefits of treated ADHD outweigh the risks of stimulant medication, particularly when the substance of concern is not a stimulant and when appropriate clinical monitoring is in place.
- For others, non-stimulant medications such as atomoxetine or certain alpha-agonists are preferred.
The decision is highly individualized and depends on the specific substance use history, the current clinical picture, the prescribing provider’s clinical judgment, and the client’s own preferences and informed consent. Our clinical team provides input on the substance use picture to support that decision-making, but the prescribing decision is made by the outside provider.
Distinguishing ADHD From Substance-Induced Cognitive Patterns
One of the diagnostic complications in this combination is that active substance use can produce cognitive patterns that look like ADHD:
- Stimulant use can produce post-use cognitive deficits that overlap with ADHD symptoms.
- Cannabis use can produce attention and memory difficulties.
- Chronic alcohol use can produce executive function difficulties.
The clinical implication is that diagnostic clarity often requires longitudinal observation across periods of sustained abstinence. Adult ADHD that persists across months of sobriety is more confidently diagnosed as primary ADHD. Symptoms that resolve with sustained abstinence may have been substance-induced. The diagnostic picture clarifies as the substance use is removed, and the treatment plan adapts accordingly.
One important clinical fact: a true diagnosis of adult ADHD generally requires evidence of symptoms in childhood, before the substance use began. The careful developmental history is part of distinguishing primary ADHD from later-onset cognitive difficulties.
Executive Function and the Practical Work of Recovery
Recovery requires sustained attention, planning, follow-through, and the management of a complex schedule of clinical appointments, medication regimens, peer support meetings, and life responsibilities. For adults with ADHD, these executive function demands can be challenging in ways that look like motivational problems but are in fact neurodevelopmental ones.
Our clinical team works with clients on practical strategies for the executive function demands of recovery. Strategies include external structure, written reminders, body-doubling techniques, simplified schedules in the early phase, and the integration of recovery tasks into existing routines rather than requiring new freestanding structures. The work is collaborative and individualized.
Integration With Other Treatment Elements
Co-occurring ADHD and substance use disorder is treated within the broader dual diagnosis framework. Co-occurring disorders describes the substance-use-primary treatment model that underlies the work. Clients receive the full range of evidence-based therapies, with adaptations for ADHD. Trauma-informed care informs the relational stance of the clinical work, given the high rates of trauma exposure in adults with ADHD. Clients with other co-occurring conditions, including anxiety and addictiondepression and addiction, receive co-occurring care for all conditions inside one substance-use-primary plan. Family members are involved through the Family Programthrough clinical family therapy sessions where indicated.
Roanoke Refuge prescribes FDA-approved MAT medications on-site. ADHD medications, antidepressants, and any other psychiatric pharmacotherapy that is part of the substance-use-primary care with co-occurring mental health addressed in the same plan plan are coordinated with community prescribers across the Roanoke region — your existing psychiatrist, primary care physician, or a new prescriber we can connect you with during admissions.
Levels of Care and Getting Started
Treatment runs substance-use-primary, with the ADHD addressed inside the same plan delivered across our outpatient levels of care. PHP at full-day outpatient offers the most intensive structure, with 25 or more clinical hours weekly. IOP at part-day outpatient provides nine or more hours weekly and is often the right level for clients with stable housing and moderate symptom severity. Telehealth IOP delivers the same curriculum virtually for clients across Botetourt, Bedford, Salem, and the rest of Southwest Virginia.
The path in begins with a confidential conversation with our admissions team. The first call covers the substance use history, the ADHD history if known, the current medications, the current symptoms, and the level of care that fits the clinical assessment. For clients who suspect undiagnosed ADHD, the conversation includes a discussion of how diagnostic clarity can be pursued during treatment. What to expect walks through the steps between the first call and the first day. Insurance verification runs alongside the clinical conversation at no cost.
Local, regional, and accessible.
Roanoke Refuge serves clients from across the Roanoke Valley — Roanoke City, Salem, Vinton, and the surrounding counties of Roanoke County, Botetourt County, and Bedford County. Our facility at 1630 Braeburn Drive in Salem sits just off I-81 exit 137, a short drive from downtown Roanoke via I-581 South and accessible from most of the Valley within 20 to 30 minutes. Whether you live near the Mill Mountain Star or out toward the Blue Ridge Parkway, the outpatient model is the same.
If a co-occurring condition alongside a substance use disorder is the picture for you or someone you love, the first step is a conversation, not a commitment. A short call with the Roanoke Refuge admissions team covers fit, level of care, and insurance — before any clinical work begins. Free, confidential insurance verification runs during the same call. Call (540) 900-0353 when you are ready.